Neglected Tropical Diseases (NTDs) Flashcards
More ntoes on diagnosis and treatments in word doc
Neglected Tropical Disease examples - Helminth NTD
Helminth: caused by parasitic worms
- Taeniasis/ Cysticerosis
- Guinea worm disease
- Enchinococcosis
- Foodborne termatodiasaes
- Soil-transmitted helminthiases
- Schistosomiasis
- Onchocerciasis
Neglected Tropical Disease Examples - Protozoan NTDs
- Chagas Disease
- Leishmaniasis
- Human African Trypanosomiasis
Fungal NTDs examples:
- Mycetoma
- chromoblastomycosis
- other deep mycoses
Viral NTDs:
Rabies
Dengue&Chikungunya
Bacterial NTDs
Buruli Ulcer
Leprosy
Trachoma
Yaws
Non-infectious diseases or conditions (NTDs)
Snakebite envenoming
Ectoparasitic NTDS
Scabies
Other Parasites
What are NTDs
-Name changing to Neglected Infectious Diseases
- Undefined taxonomic group
- Mainly tropical diseases outside teh big three (HIV/TB/Malaria) with low visibility and fewer resources
-Low asymptomatic/incubation periods
- Disproprtionally affect bottom billion (refers to approximately one billion people living in extreme poverty)
Prevalence
-Approx 1.7 billion in need of prevention or treatment
- 200,00 deather per year
- High level of diability
Stigma and health imapct
The EDCTP
- Visual lifelong symptoms: mucosal/ limb infections
- Health seeking behaviour affected: Genital-related infections
- School attendance drops during infection/treatment of children
- Causes are often poverty related: washing in certain rivers, interaction with certain biting insects.
This stimga impacts life quality, mental health and treatment options
EDCTP:European & Developing Countries Clinical Trials Partnership, partnership of european and african countries to tackle diseases affecting sub-saharan africa.
Have a portfolio of drugs, vaccines and diagnostics for various diseases including NTDs
NTDs:3 main Forms of Leishmaniasis
Cutaneous: Open sores at the site of bite
Mucocutaneous: Skin and mucus such as mouth and nose. Visceral: Infects liver, spleen, other organs: Can cause post-kala-azar dermal leishmaniasis (PDKL)- post treatment rash
Leishmaniasis Epidemiology
Visceral: 50-90k/year, 20-30k deaths
Cutaneous: 600k-1M/year, no mortaility
Statistisc for mucocutaneous lacking/ incomplete.
Leishmaniasis diagnosis - sample acquisition
Sample acquisition: Biopsy, punch or scaping of lesion fragments for Cutaneous Leishmaniasis: biopsy/ aspiration from bone marrow, lymph nodes or spleen for Visceral Leishmaniasis, serum for antibody detection of both clinical forms.
Leishmaniasis diagnosis - Lab Diangosis techniques of Leishmaniasis
Microscopy: Visualisation of mamasigtoes with Giemsa/ haemotoxylin and oesin stains upon microsopic examination of tissue specimens. In vitro and in vivo isolation: Promastigotes can be a biphasic medium using a blood agar base. Inoculation of mice/hamsters can isolate parasites. In vivo immune response: cutaneous: skin test measures delayed-type hypersensitivity to parasite anitgens. Antibody detection: Mainly used for Visceral. Commonly used techniques: ELISA, RDT, ICT (using recombinant antigens like rK39) for VL. ELISA and Western Blot used for CL. Molecular diagnosis: Based mainly on amplification via PCR. Common detection and typing techniques: PCR, DNA sequencing and LAMP
Leishmaniasis Treatment (mostly VL)
Visceral: most severe/ fatal - bigger health concern so more drugs available.
Sodium stibogluconate (SSG) , Amphotericin B - cutaenous too, Liposomal amphotericin B, Miltrefosine - cutaenous, Patamyomocyin, Pentamidine- cutaneous.
Cutaneous, mucocutaneous: topical treatments, heat therapies ( targeting parasites in skin lesions), systemic medications in more severe cases ( antimonial medications), surgery, combination therapies.